Lophos Holdings, Inc. (TSE:MESC) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Lophos Holdings Inc. concluded its annual general meeting with the election of four directors and the approval of a stock option plan, while also granting 3.26 million stock options with immediate vesting. The company’s subsidiary, Lophos Pharmaceuticals Corp., continues to excel in the biosciences sector, focusing on peyote research and sales under a special license.
For further insights into TSE:MESC stock, check out TipRanks’ Stock Analysis page.